Also categorized in PubMed:
Treatment of chronic graft versus host disease with bortezomib.
x hide permanently

Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma.

ncbi.nlm.nih.gov

Metronomic therapy has low toxicity and is as effective as current standard treatment for recurrent high-risk neuroblastoma.

Pediatr Hematol Oncol. 2017 Nov 17;:1-12

Authors: Berthold F, Hömberg M, Proleskovskaya I, Mazanek P, Belogurova M, Ernst A, Sterba J

Mentions: Treatment MYCN